Diverse functional activity of CD83+ monocyte-derived dendritic cells and the implications for cancer vaccines.
D000818:Animals; D015703:Antigens, CD; D019496:Cancer Vaccines / Q000276:immunology*; D002454:Cell Differentiation / Q000187:drug effects; D018925:Chemokines / Q000096:biosynthesis; D016207:Cytokines / Q000096:biosynthesis; D003713:Dendritic Cells / Q000276:immunology / Q000502:physiology*; D006084:Graft Rejection; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis*; D008213:Lymphocyte Activation; D008562:Membrane Glycoproteins / Q000032:analysis*; D009000:Monocytes / Q000502:physiology*; D013601:T-Lymphocytes / Q000276:immunology; D018417:Th1 Cells / Q000502:physiology; D018418:Th2 Cells / Q000502:physiology; D000097802:CD83 Antigen